SK Discovery

SK디스커버리 · 006120

Financials Diversified Financials · KOSPI

Small-cap

Market cap US$594.3M (₩820.2B)

Overview

SK Discovery is a pure holding company, listed on KOSPI (Korea's main stock exchange), that owns subsidiaries operating across several industries, including specialty chemicals, liquefied petroleum gas distribution, plasma-derived medicines, vaccines and biopharmaceuticals, real estate development, and renewable energy.

Its subsidiaries supply materials, fuels, and healthcare products to industrial and consumer end-markets across Korea. As a pure holding company, SK Discovery itself conducts no independent business operations; all commercial activity runs through its subsidiary companies.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$7.4B

▲ +12.4% YoY

Operating profit · FY2025

US$261.9M

▲ +109.4% YoY

Net income · FY2025

US$104.8M

▲ +353.1% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$6.5B(₩8.9T)	US$6.6B(₩9T)	US$7.4B(₩10.2T)
Operating profit	US$186M(₩256.7B)	US$125M(₩172.6B)	US$261.9M(₩361.4B)
Net income	US$179.6M(₩247.8B)	US$23.1M(₩31.9B)	US$104.8M(₩144.6B)

Revenue

FY2023US$6.5B
FY2024US$6.6B
FY2025US$7.4B

Operating profit

FY2023US$186M
FY2024US$125M
FY2025US$261.9M

Net income

FY2023US$179.6M
FY2024US$23.1M
FY2025US$104.8M

Key ratios (FY2025)

ROE

2.1%

Debt/Eq

137.9%

Op. margin

3.6%

Net margin

1.4%

Rev. YoY

▲ +12.4%

Why it matters

SK Discovery converted to a pure holding-company structure through a corporate split that separated its investment arm from its operating businesses, a common restructuring method among large Korean conglomerates.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?